{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:42:37Z","timestamp":1787071357323,"version":"build-2736575974"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background and purpose:<\/jats:title>\n                    <jats:p>The global emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has prompted widespread concern. Bacteriophages have recently gained attention as a cost-effective and stable alternative for vaccine development due to their adjuvant properties. This study aimed to design and validate a poly epitope composed of viral proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental approach:<\/jats:title>\n                    <jats:p>\n                      SARS-CoV-2 proteins (spike, nucleocapsid, membrane, envelope, papain-like protease, and RNA-dependent RNA polymerase) were selected for analysis. Immunoinformatic methods were employed to predict B and T cell epitopes, assessing their antigenicity, allergenicity, and toxicity. Epitopes meeting criteria for high antigenicity, non-allergenicity, and non-toxicity were linked to form poly epitopes. These sequences were synthesized and cloned into pHEN4 plasmids to generate Poly1 and Poly2 phagemid vectors. Recombinant Poly1 and Poly2 phages were produced by transforming M13\u0394III plasmids and phagemid vectors into\n                      <jats:italic toggle=\"yes\">E. coli TG1<\/jats:italic>\n                      . Female Balb\/c mice were immunized with a cocktail of Poly1 and Poly2 phages, and their serum was collected for ELISA testing. Interferon-gamma (IFN-\u03b3) testing was performed on spleen-derived lymphocytes to evaluate immune system activation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings\/Results:<\/jats:title>\n                    <jats:p>\n                      Recombinant Poly1 and Poly2 phages were produced, and their titer was determined as 10\n                      <jats:sup>13<\/jats:sup>\n                      PFU\/mL. Efficient humoral immune responses and cellular immunity activation in mice were achieved following phage administration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and implication:<\/jats:title>\n                    <jats:p>Poly epitopes displayed on phages exhibit adjuvant properties, enhancing humoral and cellular immunity in mice. This suggests that phages could serve as adjuvants to bolster immunity against SARS-Cov-2. Recombinant phages could be applied as effective candidates for injectable and oral vaccine development strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/rps.rps_82_24","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T12:00:35Z","timestamp":1729598435000},"page":"573-590","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Novel SARS-COV2 poly epitope phage-based candidate vaccine and its immunogenicity"],"prefix":"10.4103","volume":"19","author":[{"given":"Sharareh Mohammad","family":"Hasani","sequence":"first","affiliation":[{"name":"Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Behdani","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Biotechnology Research Center, Venom and Biotherapeutics Molecules Lab, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Amirkhani","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilnaz","family":"Rahimmanesh","sequence":"additional","affiliation":[{"name":"Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Esmaeilifallah","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Zaker","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Skin Diseases and Leishmaniasis Research Centre, Isfahan University of Medical Science, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh","family":"Nikpour","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Fadaie","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Skin Diseases and Leishmaniasis Research Centre, Isfahan University of Medical Science, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Ghafouri","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsi","family":"Naderi","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khanahmad","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"R1-20241030","doi-asserted-by":"crossref","first-page":"129968","DOI":"10.1016\/j.chemosphere.2021.129968","article-title":"Coronavirus and its terrifying inning around the globe: the pharmaceutical cares at the main frontline","volume":"275","author":"Ullah","year":"2021","journal-title":"Chemosphere"},{"issue":"6","key":"R2-20241030","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jmv.25748","article-title":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID\u201019) implicate special control measures","volume":"92","author":"Wang","year":"2020","journal-title":"J Med Virol"},{"key":"R3-20241030","doi-asserted-by":"crossref","first-page":"104058","DOI":"10.1016\/j.archger.2020.104058","article-title":"Clinical characteristics of older patients infected with COVID-19: a descriptive study","volume":"89","author":"Niu","year":"2020","journal-title":"Arch Gerontol Geriatr"},{"issue":"8","key":"R4-20241030","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMp2000929","article-title":"A novel coronavirus emerging in China-key questions for impact assessment","volume":"382","author":"Munster","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"R5-20241030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jiph.2020.12.025","article-title":"The find of COVID19 vaccine: challenges and opportunities","volume":"14","author":"ElBagoury","year":"2021","journal-title":"J Infect Public Health"},{"issue":"3","key":"R6-20241030","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1039\/D1CP04361G","article-title":"Binding mechanism of inhibitors to SARS-CoV-2 main protease deciphered by multiple replica molecular dynamics simulations","volume":"24","author":"Liang","year":"2022","journal-title":"Phys Chem Chem Phys"},{"issue":"230","key":"R7-20241030","doi-asserted-by":"crossref","first-page":"n230","DOI":"10.1136\/bmj.n230","article-title":"Covid-19: new UK variant may be linked to increased death rate, early data indicate","volume":"372","author":"Iacobucci","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"R8-20241030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jiph.2020.12.009","article-title":"The growing complexity of COVID-19 drug and vaccine candidates: challenges and critical transitions","volume":"14","author":"Shariare","year":"2021","journal-title":"J Infect Public Health"},{"issue":"2","key":"R9-20241030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cvsm.2017.10.002","article-title":"Recent advances in vaccine technologies","volume":"48","author":"Francis","year":"2018","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"1","key":"R10-20241030","first-page":"9313267","article-title":"The key to increase immunogenicity of next\u2010generation COVID\u201019 vaccines lies in the inclusion of the SARS\u2010CoV\u20102 nucleocapsid protein","volume":"2024","author":"Mendoza-Ram\u00edrez","year":"2024","journal-title":"J Immunol Res"},{"issue":"4","key":"R11-20241030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","volume":"27","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"key":"R12-20241030","doi-asserted-by":"crossref","first-page":"105387","DOI":"10.1016\/j.ejps.2020.105387","article-title":"Design of a novel multi epitope-based vaccine for pandemic coronavirus disease (COVID-19) by vaccinomics and probable prevention strategy against avenging zoonotics","volume":"151","author":"Ahmad","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"R13-20241030","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jmv.25736","article-title":"Development of epitopebased peptide vaccine against novel coronavirus 2019 (SARS\u2010COV\u20102): immunoinformatics approach","volume":"92","author":"Bhattacharya","year":"2020","journal-title":"J Med Virol"},{"key":"R14-20241030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2683286","article-title":"Design of a multiepitope-based peptide vaccine against the E protein of human COVID-19: an immunoinformatics approach","volume":"2020","author":"Abdelmageed","year":"2020","journal-title":"Biomed Res Int"},{"issue":"10","key":"R15-20241030","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.vaccine.2009.12.059","article-title":"Engineering filamentous phage carriers to improve focusing of antibody responses against peptides","volume":"28","author":"van Houten","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"R16-20241030","doi-asserted-by":"crossref","first-page":"e10142","DOI":"10.1002\/btm2.10142","article-title":"Phage display as a tool for vaccine and immunotherapy development","volume":"5","author":"Hess","year":"2020","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"R17-20241030","first-page":"63","article-title":"MHCPred: bringing a quantitative dimension to the online prediction of MHC binding","volume":"2","author":"Guan","year":"2003","journal-title":"Appl Bioinformatics"},{"issue":"6","key":"R18-20241030","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","article-title":"Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data","volume":"19","author":"Reynisson","year":"2020","journal-title":"J Proteome Res"},{"issue":"1","key":"R19-20241030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B\u2010cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"R20-20241030","first-page":"1","article-title":"BcePred: prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties","volume":"3239","author":"Saha","year":"2004","journal-title":"Artif Intel Res"},{"issue":"1","key":"R21-20241030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"R22-20241030","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2--a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J Mol Model"},{"issue":"9","key":"R23-20241030","doi-asserted-by":"crossref","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PloS One"},{"issue":"W1","key":"R24-20241030","doi-asserted-by":"crossref","first-page":"W402","DOI":"10.1093\/nar\/gkz297","article-title":"The PSIPRED protein analysis workbench: 20 years on","volume":"47","author":"Buchan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R25-20241030","first-page":"571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005","journal-title":"Springer"},{"issue":"10","key":"R26-20241030","doi-asserted-by":"crossref","first-page":"23262353","DOI":"10.1038\/s41596-022-00728-0","article-title":"I-TASSER-MTD: a deep-learning-based platform for multi-domain protein structure and function prediction","volume":"17","author":"Zhou","year":"2022","journal-title":"Nat Protoc"},{"issue":"W1","key":"R27-20241030","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"R28-20241030","doi-asserted-by":"crossref","first-page":"W431","DOI":"10.1093\/nar\/gkv495","article-title":"GalaxyPepDock: a protein-peptide docking tool based on interaction similarity and energy optimization","volume":"43","author":"Lee","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"R29-20241030","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2144\/00286ir01","article-title":"The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences","volume":"28","author":"Stothard","year":"2000","journal-title":"Biotechniques"},{"issue":"suppl_2","key":"R30-20241030","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: a novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"R31-20241030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fmicb.2015.00340","article-title":"Intradomain phage display (ID-PhD) of peptides and protein mini-domains censored from canonical pIII phage display","volume":"6","author":"Tjhung","year":"2015","journal-title":"Front Microbiol"},{"key":"R32-20241030","first-page":"129","article-title":"Preparation of competent cells for high-efficiency plasmid transformation of Escherichia coli","author":"Nakata","year":"1997","journal-title":"cDNA Libr Protoc"},{"issue":"5","key":"R33-20241030","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019\u2010nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"Chembiochem"},{"issue":"16","key":"R34-20241030","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1080\/07391102.2018.1548977","article-title":"Design of novel multiepitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamics","volume":"37","author":"Srivastava","year":"2019","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"R35-20241030","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/s41598-019-39299-8","article-title":"Designing a multi-epitope based vaccine to combat kaposi sarcoma utilizing immunoinformatics approach","volume":"9","author":"Chauhan","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"R36-20241030","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4103\/1735-5362.327503","article-title":"Anti-angiogenic peptides application in cancer therapy; a review","volume":"16","author":"Shoari","year":"2021","journal-title":"Res Pharm Sci"},{"issue":"9","key":"R37-20241030","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/cmi.2017.3","article-title":"Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model","volume":"15","author":"He","year":"2018","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"R38-20241030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-1353-1","article-title":"Characterization of Sarcoptes scabiei cofilin gene and assessment of recombinant cofilin protein as an antigen in indirect-ELISA for diagnosis","volume":"16","author":"Zheng","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"5","key":"R39-20241030","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4161\/hv.28371","article-title":"Cholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice","volume":"10","author":"Hou","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"R40-20241030","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF02977620","article-title":"Intranasal vaccination with peptides and cholera toxin subunit B as adjuvant to enhance mucosal and systemic immunity to respiratory syncytial virus","volume":"30","author":"Kim","year":"2007","journal-title":"Arch Pharm Res"},{"issue":"6","key":"R41-20241030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0264-410X(89)90273-9","article-title":"Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite preexisting immunity to CTB","volume":"7","author":"Tamura","year":"1989","journal-title":"Vaccine"},{"key":"R42-20241030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.meegid.2017.02.007","article-title":"A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: an in silico approach","volume":"49","author":"Meza","year":"2017","journal-title":"Infect Genet Evol"},{"issue":"1","key":"R43-20241030","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1038\/s41598-017-08842-w","article-title":"Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach","volume":"7","author":"Khatoon","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"R44-20241030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/vaccines7020034","article-title":"In silico designed Ebola virus T-cell multi-epitope DNA vaccine constructions are immunogenic in mice","volume":"7","author":"Bazhan","year":"2019","journal-title":"Vaccines"},{"issue":"suppl_2","key":"R45-20241030","doi-asserted-by":"crossref","first-page":"W202","DOI":"10.1093\/nar\/gkl343","article-title":"AlgPred: prediction of allergenic proteins and mapping of IgE epitopes","volume":"34","author":"Saha","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"R46-20241030","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2020.01581","article-title":"COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning","volume":"11","author":"Ong","year":"2020","journal-title":"Front immunol"},{"issue":"4","key":"R47-20241030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bib\/bbac190","article-title":"COVID-19 vaccine design using reverse and structural vaccinology, ontology-based literature mining and machine learning","volume":"23","author":"Huffman","year":"2022","journal-title":"Brief Bioinform"},{"key":"R48-20241030","first-page":"571","article-title":"The proteomics protocols handbook","author":"Walker","year":"2005","journal-title":"Springer"},{"issue":"5","key":"R49-20241030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1586\/14760584.2014.907528","article-title":"Physicochemical and functional characterization of vaccine antigens and adjuvants","volume":"13","author":"Dey","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"R50-20241030","doi-asserted-by":"crossref","first-page":"100013","DOI":"10.1016\/j.vetvac.2023.100013","article-title":"Design of multiepitope vaccine candidate from a major capsid protein of the African swine fever virus","volume":"2","author":"Rowaiye","year":"2023","journal-title":"Vet Vaccine"},{"key":"R51-20241030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-021-00412-0","article-title":"Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","volume":"22","author":"Almofti","year":"2021","journal-title":"BMC Immunol"},{"issue":"2","key":"R52-20241030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/1735-5362.367795","article-title":"A comparative study of the arazyme-based fusion proteins with various ligands for more effective targeting cancer therapy: an insilico analysis","volume":"18","author":"Mehrab","year":"2023","journal-title":"Res Pharm Sci"},{"issue":"10","key":"R53-20241030","doi-asserted-by":"crossref","first-page":"e0223844","DOI":"10.1371\/journal.pone.0223844","article-title":"Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides","volume":"14","author":"Kardani","year":"2019","journal-title":"PLoS One"},{"key":"R54-20241030","doi-asserted-by":"crossref","first-page":"100578","DOI":"10.1016\/j.imu.2021.100578","article-title":"Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2","volume":"24","author":"Khan","year":"2021","journal-title":"Inform Med Unlocked"},{"issue":"3","key":"R55-20241030","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.aej.2021.01.046","article-title":"Immunoinformatics based prediction of recombinant multi-epitope vaccine for the control and prevention of SARS-CoV-2","volume":"60","author":"Rasheed","year":"2021","journal-title":"Alex Eng J"},{"issue":"7","key":"R56-20241030","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jiph.2021.04.010","article-title":"Design of a novel multiple epitope-based vaccine: an immunoinformatics approach to combat SARS-CoV-2 strains","volume":"14","author":"Naveed","year":"2021","journal-title":"J Infect Public Health"},{"key":"R57-20241030","doi-asserted-by":"crossref","first-page":"100338","DOI":"10.1016\/j.imu.2020.100338","article-title":"Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach","volume":"19","author":"Joshi","year":"2020","journal-title":"Inform Med Unlocked"},{"key":"R58-20241030","doi-asserted-by":"crossref","first-page":"100478","DOI":"10.1016\/j.imu.2020.100478","article-title":"Engineering a novel subunit vaccine against SARSCoV-2 by exploring immunoinformatics approach","volume":"21","author":"Sarkar","year":"2020","journal-title":"Inform Med Unlocked"},{"issue":"1","key":"R59-20241030","first-page":"345","article-title":"Immunoinformatics approaches to explore B and T cell epitope-based vaccine designing for SARS-CoV-2 Virus","volume":"34","author":"Bashir","year":"2021","journal-title":"Pak J Pharm Sci"},{"key":"R60-20241030","doi-asserted-by":"crossref","first-page":"587615","DOI":"10.3389\/fimmu.2020.587615","article-title":"Immunoinformatic analysis of SARS-CoV-2 nucleocapsid protein and identification of COVID-19 vaccine targets","volume":"11","author":"Oliveira","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"R61-20241030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4103\/1735-5362.192496","article-title":"Expression and purification of truncated diphtheria toxin, DT386, in Escherichia coli: an attempt for production of a new vaccine against diphtheria","volume":"11","author":"Shafiee","year":"2016","journal-title":"Res Pharm Sci"},{"issue":"3","key":"R62-20241030","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/vaccines8030504","article-title":"Bacteriophage-based vaccines: a potent approach for antigen delivery","volume":"8","author":"Gonz\u00e1lez-Mora","year":"2020","journal-title":"Vaccines"},{"issue":"5","key":"R63-20241030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/1735-5362.213982","article-title":"Isolation of bacteriophages against multidrug resistant Acinetobacter baumannii","volume":"12","author":"Ghajavand","year":"2017","journal-title":"Res Pharm Sci"},{"issue":"30","key":"R64-20241030","doi-asserted-by":"crossref","first-page":"e2105739118","DOI":"10.1073\/pnas.2105739118","article-title":"Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain","volume":"118","author":"Staquicini","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"R65-20241030","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice","volume":"12","author":"Tian","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"R66-20241030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41541-020-00243-x","article-title":"Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses","volume":"5","author":"Bos","year":"2020","journal-title":"NPJ Vaccines"}],"container-title":["Research in Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/RPS.RPS_82_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:44:52Z","timestamp":1787067892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/RPS.RPS_82_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/rps.rps_82_24","relation":{},"ISSN":["1735-5362","1735-9414"],"issn-type":[{"value":"1735-5362","type":"print"},{"value":"1735-9414","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"2024-05-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}